Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425939 · ClinicalTrials.gov registry record · NA
Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Exercise Performance
A NA study of Exercise and Heart Rate Variability, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT06425939 is a NA study of Exercise and Heart Rate Variability that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 50 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06425939, a NA study of Exercise and Heart Rate Variability, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
Heart rate variability (HRV) is a measure of the variation in time between each heartbeat. It is an indirect and ubiquitous biomarker of performance readiness and recovery measured by most consumer-grade wearable fitness trackers. However, there is little documented on the relationship between HRV, training load, and performance measures in the Real-World. Whoop wrist-worn activity trackers have been validated against the gold-standard Electrocardiography (ECG) for HRV and HR measurements. Whoop leverages photoplethysmography (PPG) technology to continuously track (HR, HRV, respiratory rate, energy expenditure) and provides, daily, individual insights, trends, and coaching to improve strain, sleep, and recovery. Research has demonstrated that heart rate variability (HRV) guided training may be more optimal compared to predetermined training for aerobic exercise improvements. The purpose of this study is to assess the feasibility of providing personalized training recommendations based on HRV measured by a consumer-grade wearable (Whoop) in a real-world setting to better understand the HRV relationship with performance.
Conditions Studied
Interventions
- OTHER Force plate assessment
- DEVICE Whoop wrist band
Study Locations (2)
Illinois
- PepsiCo R&D, Gatorade Sports Science Institute - Chicago
Texas
- PepsiCo R&D, Gatorade Sports Science Institute - Frisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-05-08 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06425939
The ClinicalTrials.gov registry entry for NCT06425939 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Force plate assessment is the first listed.
NCT06425939 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Texas.
Frequently Asked Questions
What is clinical trial NCT06425939 about?
NCT06425939 is a clinical study titled "Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Exercise Performance". Heart rate variability (HRV) is a measure of the variation in time between each heartbeat. It is an indirect and ubiquitous biomarker of performance readiness and recovery measured by most consumer-grade wearable fitness trackers. However, there is little documented on the relationship between HRV,...
What is the current status of trial NCT06425939?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-05-08. Estimated completion is 2024-09-30.
What conditions does trial NCT06425939 study?
This clinical trial studies the following conditions: Exercise, Heart Rate Variability.
What interventions are being tested in trial NCT06425939?
The interventions under investigation include: Force plate assessment (OTHER), Whoop wrist band (DEVICE).
Who is sponsoring clinical trial NCT06425939?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06425939 being conducted?
This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.